Cardiac-specific genetic inhibition of nuclear factor-κB prevents right ventricular hypertrophy induced by monocrotaline

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 302, Issue 8, 2012, Pages

  Kumar, Sandeep ^a,b,c   Wei, Chuanyu ^a,b,c   Thomas, Candice M ^a,b,c   Kim, Il Kwon ^a,b,c   Seqqat, Rachid ^a,b,c   Kumar, Rajesh ^a,b,c   Baker, Kenneth M ^a,b,c   Jones, W Keith ^d   Gupta, Sudhiranjan ^a,b,c  

^a Department of Obstetrics and Gynecology   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Cell signaling; I B ; Inflammation; Pulmonary arterial hypertension

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCROTALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HEART FAILURE; HEART OUTPUT; HEART RIGHT VENTRICLE HYPERTROPHY; MALE; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ANIMALS; BLOTTING, WESTERN; CELL ADHESION MOLECULES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HEART; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; I-KAPPA B PROTEINS; INFLAMMATION; MALE; MICE; MONOCROTALINE; MYOCARDIUM; NF-KAPPA B; POISONS; REAL-TIME POLYMERASE CHAIN REACTION; RNA; SIGNAL TRANSDUCTION; VENTRICULAR REMODELING;

EID: 84859779898     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00756.2011     Document Type: Article

References (57)

1. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 284: 770-776, 1999.
2. Bellavia D, Campese AF, Alesse E, Vacca A, Felli MP, Balestri A, Stoppacciaro A, Tiveron C, Tatangelo L, Giovarelli M, Gaetano C, Ruco L, Hoffman ES, Hayday AC, Lendahl U, Frati L, Gulino A, Screpanti I. Constitutive activation of NF-[kappa]B and T-cell leukemia/lymphoma in Notch3 transgenic mice. EMBO J 19: 3337-3348, 2000.
3. Bitzer M, von Gersdorff G, Liang D, Dominguez-Rosales A, Beg AA, Rojkind M, Bottinger EP. A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappaB/RelA. Genes Dev 14: 187-197, 2000.
4. Blackwell TS, Christman JW. The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol 17: 3-9, 1997.
5. Bossone E, Bodini BD, Mazza A, Allegra L. Pulmonary arterial hypertension: the key role of echocardiography. Chest 127: 1836-1843, 2005.
6. Brown M, McGuinness M, Wright T, Ren X, Wang Y, Boivin GP, Hahn H, Feldman AM, Jones WK. Cardiac-specific blockade of NF-κB in cardiac pathophysiology: differences between acute and chronic stimuli in vivo. Am J Physiol Heart Circ Physiol 289: H466-H476, 2005.
7. Chen F, Castranova V, Shi X, Demers LM. New insights into the role of nuclear factor-kappab, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 45: 7-17, 1999.
8. Clement N, Gueguen M, Glorian M, Blaise R, Andreani M, Brou C, Bausero P, Limon I. Notch3 and IL-1beta exert opposing effects on a vascular smooth muscle cell inflammatory pathway in which NF-kappaB drives crosstalk. J Cell Sci 120: 3352-3361, 2007.
9. D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT, Rich S, Vreim CE, Williams GW, Wu M. Survival in patients with primary pulmonary hypertension Results from a national prospective registry. Ann Intern Med 115: 343-349, 1991.
10. D'Angelo DD, Sakata Y, Lorenz JN, Boivin GP, Walsh RA, Liggett SB, Dorn GW 2nd. Transgenic Galphaq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci USA 94: 8121-8126, 1997.
11. Dorfmüller P, Perros F, Balabanian K, Humbert M. Inflammation in pulmonary arterial hypertension. Eur Respir J 22: 358-363, 2003.
12. Feng JQ, Xing L, Zhang JH, Zhao M, Horn D, Chan J, Boyce BF, Harris SE, Mundy GR, Chen D. NF-kappaB specifically activates BMP-2 gene expression in growth plate chondrocytes in vivo and in a chondrocyte cell line in vitro. J Biol Chem 278: 29130-29135, 2003.
13. Ghodsi F, Will JA. Changes in pulmonary structure and function induced by monocrotaline intoxication. Am J Physiol Heart Circ Physiol 240: H149-H155, 1981.
14. Gupta S, Young D, Maitra RK, Gupta A, Popovic ZB, Yong SL, Mahajan A, Wang Q, Sen S. Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB. J Mol Biol 375: 637-649, 2008.
15. Haunstetter A, Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res 82: 1111-1129, 1998.
16. Heldin CH, Miyazono K, ten Dijke P. TGF-[beta] signalling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471, 1997.
17. Huang J, Kaminski PM, Edwards JG, Yeh A, Wolin MS, Frishman WH, Gewitz MH, Mathew R. Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline-induced pulmonary artery hypertension. Am J Physiol Lung Cell Mol Physiol 294: L1250-L1259, 2008.
18. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF, Rabinovitch M. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43: 13S-24S, 2004.
19. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 351: 1425-1436, 2004.
20. Kimura H, Kasahara Y, Kurosu K, Sugito K, Takiguchi Y, Terai M, Mikata A, Natsume M, Mukaida N, Matsushima K, Kuriyama T. Alleviation of monocrotaline-induced pulmonary hypertension by antibodies to monocyte chemotactic and activating factor monocyte chemoattractant protein-1. Lab Invest 78: 571-581, 1998.
21. Kumar S, Seqqat R, Chigurupati S, Kumar R, Baker KM, Young D, Sen S, Gupta S. Inhibition of nuclear factor kappaB regresses cardiac hypertrophy by modulating the expression of extracellular matrix and adhesion molecules. Free Radic Biol Med 50: 206-215, 2011.
22. LaRaia AV, Waxman AB. Pulmonary arterial hypertension: evaluation and management. South Med J 100: 393-399, 2007.
23. Lee R, Collins T. Nuclear factor-kappaB and cell survival: IAPs call for support. Circ Res 88: 262-264, 2001.
24. Li X, Zhang X, Leathers R, Makino A, Huang C, Parsa P, Macias J, Yuan JXJ, Jamieson SW, Thistlethwaite PA. Notch3 signaling pro-motes the development of pulmonary arterial hypertension. Nat Med 15: 1289-1297, 2009.
25. Liu GG, Fong E, Zeng X. GNCPro: navigate human genes and relationships through net-walking. Adv Exp Med Biol 680: 253-259, 2010.
26. Lopez-Rovira T, Chalaux E, Rosa JL, Bartrons R, Ventura F. Interaction and functional cooperation of NF-kappa B with Smads. Transcriptional regulation of the junB promoter. J Biol Chem 275: 28937-28946, 2000.
27. Lowery JW, Frump AL, Anderson L, Dicarlo GE, Jones MT, de Caestecker MP. ID family protein expression and regulation in hypoxic pulmonary hypertension. Am J Physiol Regul Integr Comp Physiol 299: R1463-R1477, 2010.
28. Madl AK, Wilson DW, Segall HI, Pinkerton KE. Alteration in lung particle translocation, macrophage function, and microfilament arrangement in monocrotaline-treated rats. Toxicol Appl Pharmacol 153: 28-38, 1998.
29. Mani K, Kitsis RN. Myocyte apoptosis: programming ventricular remodeling. J Am Coll Cardiol 41: 761-764, 2003.
30. Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, Barre-Dirrie A, Reuter I, Chekmenev D, Krull M, Hornischer K, Voss N, Stegmaier P, Lewicki-Potapov B, Saxel H, Kel AE, Wingender E. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res 34: D108-D110.
31. McKay JA, Murray GI, Ewen SWB, Melvin WT, Burke MD. Immunohistochemical localization of glutathione s-transferases in sarcomas. J Pathol 174: 83-87, 1994.
32. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society; and the Pulmonary Hypertension Association. J Am Coll Cardiol 53: 1573-1619, 2009.
33. Nagarajan RP, Chen F, Li W, Vig E, Harrington MA, Nakshatri H, Chen Y. Repression of transforming-growth-factor-beta-mediated transcription by nuclear factor kappaB. Biochem J 348: 591-596, 2000.
34. Narula J, Kharbanda S, Khaw BA. Apoptosis and the heart. Chest 112: 1358-1362, 1997.
35. Nemir M, Pedrazzini T. Functional role of Notch signaling in the developing and postnatal heart. J Mol Cell Cardiol 45: 495-504, 2008.
36. Nian M, Lee P, Khaper N, Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 94: 1543-1553, 2004.
37. Niessen K, Karsan A. Notch signaling in cardiac development. Circ Res 102: 1169-1181, 2008.
38. Ogata T, Wozney JM, Benezra R, Noda M. Bone morphogenetic protein 2 transiently enhances expression of a gene, Id (inhibitor of differentiation), encoding a helix-loop-helix molecule in osteoblast-like cells. Proc Natl Acad Sci USA 90: 9219-9222, 1993.
39. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853-6866, 1999.
40. Pantano C, Reynaert NL, van der Vliet A, Janssen-Heininger YM.Redox-sensitive kinases of the nuclear factor-kappaB signaling pathway. Antioxid Redox Signal 8: 1791-1806, 2006.
41. Rahman I, Adcock IM. Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J 28: 219-242, 2006.
42. Rubin LJ. Primary pulmonary hypertension. N Engl J Med 336: 111-117, 1997.
43. Sakuma F, Miyata M, Kasukawa R. Suppressive effect of prostaglandin E1 on pulmonary hypertension induced by monocrotaline in rats. Lung 177: 77-88, 1999.
44. Sandoval J, Bauerle O, Palomar A, Gomez A, Martinez-Guerra ML, Beltran M, Guerrero ML. Survival in primary pulmonary hypertension. Validation of a prognostic equation. Circulation 89: 1733-1744, 1994.
45. Schug J. Using TESS to predict transcription factor binding sites in DNA sequence. In: Current Protocols in Bioinformatics. New York: John Wiley & Sons, 2002.
46. Schultz JE, Witt SA, Nieman ML, Reiser PJ, Engle SJ, Zhou M, Pawlowski SA, Lorenz JN, Kimball TR, Doetschman T. Fibroblast growth factor-2 mediates pressure-induced hypertrophic response. J Clin Invest 104: 709-719, 1999.
47. Schultz Jel J, Witt SA, Glascock BJ, Nieman ML, Reiser PJ, Nix SL, Kimball TR, Doetschman T. TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. J Clin Invest 109: 787-796, 2002.
48. Schultze AE, Roth RA. Chronic pulmonary hypertension-the monocrotaline model and involvement of the hemostatic system. J Toxicol Environ Health 1: 271-346, 1998.
49. Simon MA. Right ventricular adaptation to pressure overload. Curr Opin Crit Care 16: 237-243, 2010.
50. Skaug B, Jiang X, Chen ZJ. The role of ubiquitin in NF-kappaB regulatory pathways. Annu Rev Biochem 78: 769-796, 2009.
51. Thoss K, Roth J. The use of fluorescein isothiocyanate labelled lectins for immuno-histological demonstration of saccharides. III. Studies by use of Ricinus communis lectin and wheat germ agglutinin. Exp Pathol (Jena) 14: 215-219, 1977.
52. Valen G, Yan ZQ, Hansson GK. Nuclear factor kappa-B and the heart. J Am Coll Cardiol 38: 307-314, 2001.
53. Voelkel NF, Tuder RM. Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension. Eur Respir J 8: 2129-2138, 1995.
54. Wilson DW, Segall HJ, Pan LC, Lame MW, Estep JE, Morin D. Mechanisms and pathology of monocrotaline pulmonary toxicity. Crit Rev Toxicol 22: 307-325, 1992.
55. Xue J, Thippegowda PB, Hu G, Bachmaier K, Christman JW, Malik AB, Tiruppathi C. NF-kappaB regulates thrombin-induced ICAM-1 gene expression in cooperation with NFAT by binding to the intronic NFkappaB site in the ICAM-1 gene. Physiol Genomics 38: 42-53, 2009.
56. Yang Z, Song L, Huang C. Gadd45 proteins as critical signal transducers linking NF-kappaB to MAPK cascades. Curr Cancer Drug Targets 9: 915-930, 2009.
57. Yokota Y, Mori S. Role of Id family proteins in growth control. J Cell Physiol 190: 21-28, 2002.